112 related articles for article (PubMed ID: 26346763)
1. Comparing two assays for clinical genomic profiling: the devil is in the data.
Squillace RM; Frampton GM; Stephens PJ; Ross JS; Miller VA
Onco Targets Ther; 2015; 8():2237-42. PubMed ID: 26346763
[No Abstract] [Full Text] [Related]
2. Comparing two assays for clinical genomic profiling: the devil is in the data [Letter of clarification].
Weiss GJ; Khemka V
Onco Targets Ther; 2015; 8():2643. PubMed ID: 26425099
[No Abstract] [Full Text] [Related]
3. Identification and analysis of divergent immune gene families within the Tasmanian devil genome.
Morris KM; Cheng Y; Warren W; Papenfuss AT; Belov K
BMC Genomics; 2015 Nov; 16():1017. PubMed ID: 26611146
[TBL] [Abstract][Full Text] [Related]
4. Sex determination by SRY PCR and sequencing of Tasmanian devil facial tumour cell lines reveals non-allograft transmission.
Cui X; Wang Y; Hua B; Miller W; Zhao Y; Cui H; Kong X
Biochem Biophys Res Commun; 2016 May; 474(1):29-34. PubMed ID: 27084454
[TBL] [Abstract][Full Text] [Related]
5. Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes.
Ingles ED; Deakin JE
Mol Cytogenet; 2015; 8():74. PubMed ID: 26435750
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells.
Patchett AL; Wilson R; Charlesworth JC; Corcoran LM; Papenfuss AT; Lyons BA; Woods GM; Tovar C
Oncotarget; 2018 Mar; 9(22):15895-15914. PubMed ID: 29662615
[TBL] [Abstract][Full Text] [Related]
7. Growth, productivity, and relative extinction risk of a data-sparse devil ray.
Pardo SA; Kindsvater HK; Cuevas-Zimbrón E; Sosa-Nishizaki O; Pérez-Jiménez JC; Dulvy NK
Sci Rep; 2016 Sep; 6():33745. PubMed ID: 27658342
[TBL] [Abstract][Full Text] [Related]
8. Development of a SNP-based assay for measuring genetic diversity in the Tasmanian devil insurance population.
Wright B; Morris K; Grueber CE; Willet CE; Gooley R; Hogg CJ; O'Meally D; Hamede R; Jones M; Wade C; Belov K
BMC Genomics; 2015 Oct; 16():791. PubMed ID: 26467759
[TBL] [Abstract][Full Text] [Related]
9. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
Hubert JN; Zerjal T; Hospital F
PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
[TBL] [Abstract][Full Text] [Related]
10. Devil Facial Tumours: Towards a Vaccine.
Owen RS; Siddle HV
Immunol Invest; 2019 Oct; 48(7):719-736. PubMed ID: 31161832
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of Cryptosporidium and Giardia from the Tasmanian devil (Sarcophilus harrisii).
Wait LF; Fox S; Peck S; Power ML
PLoS One; 2017; 12(4):e0174994. PubMed ID: 28423030
[TBL] [Abstract][Full Text] [Related]
12. The Devil We Don't Know: Investigating Habitat and Abundance of Endangered Giant Devil Rays in the North-Western Mediterranean Sea.
Notarbartolo di Sciara G; Lauriano G; Pierantonio N; Cañadas A; Donovan G; Panigada S
PLoS One; 2015; 10(11):e0141189. PubMed ID: 26580814
[TBL] [Abstract][Full Text] [Related]
13. Sympathy for the devil: a conservation strategy for devil and manta rays.
Lawson JM; Fordham SV; O'Malley MP; Davidson LN; Walls RH; Heupel MR; Stevens G; Fernando D; Budziak A; Simpfendorfer CA; Ender I; Francis MP; Notarbartolo di Sciara G; Dulvy NK
PeerJ; 2017; 5():e3027. PubMed ID: 28316882
[TBL] [Abstract][Full Text] [Related]
14. Genomic insights into a contagious cancer in Tasmanian devils.
Grueber CE; Peel E; Gooley R; Belov K
Trends Genet; 2015 Sep; 31(9):528-35. PubMed ID: 26027792
[TBL] [Abstract][Full Text] [Related]
15. Dental Pulp Stem Cells - Exploration in a Novel Animal Model: the Tasmanian Devil (Sarcophilus harrisii).
Graham CM; Kremer KL; Koblar SA; Hamilton-Bruce MA; Pyecroft SB
Stem Cell Rev Rep; 2018 Aug; 14(4):500-509. PubMed ID: 29737458
[TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
Brown GK; Tovar C; Cooray AA; Kreiss A; Darby J; Murphy JM; Corcoran LM; Bettiol SS; Lyons AB; Woods GM
Immunol Cell Biol; 2016 Aug; 94(7):673-9. PubMed ID: 27089941
[TBL] [Abstract][Full Text] [Related]
18. Relaxation of risk-sensitive behaviour of prey following disease-induced decline of an apex predator, the Tasmanian devil.
Hollings T; McCallum H; Kreger K; Mooney N; Jones M
Proc Biol Sci; 2015 Jul; 282(1810):. PubMed ID: 26085584
[TBL] [Abstract][Full Text] [Related]
19. The identification of immune genes in the milk transcriptome of the Tasmanian devil (Sarcophilus harrisii).
Hewavisenti RV; Morris KM; O'Meally D; Cheng Y; Papenfuss AT; Belov K
PeerJ; 2016; 4():e1569. PubMed ID: 26793426
[TBL] [Abstract][Full Text] [Related]
20. Lack of genetic diversity across diverse immune genes in an endangered mammal, the Tasmanian devil (Sarcophilus harrisii).
Morris KM; Wright B; Grueber CE; Hogg C; Belov K
Mol Ecol; 2015 Aug; 24(15):3860-72. PubMed ID: 26119928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
